Jon Lenihan joined AST in 2026. As Chief Commercial Officer, Jon leads the Business Development and Marketing teams to provide customers with proven cGMP solutions for navigating the final mile of drug delivery. With over 20 years of commercial strategy and biopharmaceutical experience at companies including Vetter Pharma, Thermo Fisher Scientific, and Emergent BioSolutions, Jon plays an integral role in driving AST’s global expansion and strategic partnerships.

Jon holds an M.B.A. and an M.S. in Finance from Northeastern University, an M.S. in Cellular & Molecular Biology from the University of Cincinnati, and a B.S. in Biology from Xavier University.